bioAffinity Technologies (BIAF) Short Interest Ratio & Short Volume $0.24 0.00 (-0.30%) As of 02:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock bioAffinity Technologies Short Interest DatabioAffinity Technologies (BIAF) has a short interest of 985,900 shares, representing 4.78% of the float (the number of shares available for trading by the public). This marks a -12.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 6.38 million shares to cover all short positions.Current Short Interest985,900 sharesPrevious Short Interest1,130,000 sharesChange Vs. Previous Month-12.75%Dollar Volume Sold Short$229.81 thousandShort Interest Ratio0.2 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares28,470,000 sharesFloat Size20,610,000 sharesShort Percent of Float4.78%Today's Trading Volume702,150 sharesAverage Trading Volume6,382,963 sharesToday's Volume Vs. Average11% Short Selling bioAffinity Technologies? Sign up to receive the latest short interest report for bioAffinity Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIAF Short Interest Over TimeBIAF Days to Cover Over TimeBIAF Percentage of Float Shorted Over Time bioAffinity Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2025985,900 shares $229.81 thousand -12.8%4.8%0.2 $0.23 7/31/20251,130,000 shares $358.21 thousand -11.0%5.5%0.2 $0.32 7/15/20251,270,000 shares $371.98 thousand -71.1%6.2%0.2 $0.29 6/30/20254,390,000 shares $1.26 million +471.0%21.3%0.7 $0.29 6/15/2025768,900 shares $211.76 thousand -52.2%3.8%0.1 $0.28 5/31/20251,610,000 shares $471.09 thousand +250.4%9.9%0.1 $0.29 5/15/2025459,500 shares $94.47 thousand +58.8%2.3%0 $0.21 4/30/2025289,300 shares $135.97 thousand -20.2%2.6%0 $0.47 4/15/2025362,600 shares $180.86 thousand +44.5%3.3%0 $0.50 3/31/2025250,900 shares $65.23 thousand +4.6%2.3%0 $0.26 Get the Latest News and Ratings for BIAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter. 3/15/2025239,800 shares $88.01 thousand +107.6%2.6%0.9 $0.37 2/28/2025115,500 shares $57.75 thousand -54.2%1.2%0.6 $0.50 2/15/2025251,900 shares $202.78 thousand -36.5%2.7%1.4 $0.81 1/31/2025396,800 shares $301.57 thousand -7.2%4.2%2.3 $0.76 1/15/2025427,500 shares $320.63 thousand +275.0%4.5%2.3 $0.75 12/31/2024114,000 shares $103.74 thousand -35.8%1.2%0.8 $0.91 12/15/2024177,500 shares $165.08 thousand +33.4%1.9%1.2 $0.93 11/30/2024133,100 shares $161.72 thousand -41.2%1.4%1 $1.22 11/15/2024226,200 shares $296.32 thousand -16.7%2.4%1.8 $1.31 10/31/2024271,400 shares $388.10 thousand -39.4%3.7%2.4 $1.43 10/15/2024447,500 shares $886.05 thousand +13.0%6.0%3.2 $1.98 9/30/2024396,200 shares $824.10 thousand +18.0%5.3%3.6 $2.08 9/15/2024335,900 shares $584.47 thousand +59.3%4.5%3 $1.74 8/31/2024210,900 shares $316.35 thousand -27.8%2.8%2 $1.50 8/15/2024291,900 shares $504.99 thousand -58.8%4.5%2.7 $1.73 7/31/2024708,000 shares $1.76 million +17.3%12.6%5.9 $2.49 7/15/2024603,700 shares $1.53 million +9.3%10.7%6 $2.53 6/30/2024552,600 shares $1.19 million -1.9%9.8%4.9 $2.16 6/15/2024563,400 shares $1.13 million +8.7%9.6%4.6 $2.00 5/31/2024518,400 shares $1.24 million +22.6%8.6%3.2 $2.40 5/15/2024423,000 shares $795.24 thousand +7.1%7.1%1.7 $1.88 4/30/2024395,000 shares $967.75 thousand +64.0%6.7%1.7 $2.45 4/15/2024240,900 shares $664.88 thousand +337.2%4.4%1.1 $2.76 3/31/202455,100 shares $111.30 thousand -12.1%1.3%0.3 $2.02 3/15/202462,700 shares $119.13 thousand +148.8%1.8%0.4 $1.90 2/29/202425,200 shares $58.46 thousand +159.8%0.7%0.2 $2.32 2/15/20249,700 shares $14.65 thousand +73.2%0.3%0.4 $1.51 1/31/20245,600 shares $8.79 thousand -60.6%0.2%0.4 $1.57 1/15/202414,200 shares $21.16 thousand -47.6%0.4%1 $1.49 12/31/202327,100 shares $39.85 thousand -45.3%0.7%2 $1.47What's the Best Way to Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today. 12/15/202349,500 shares $76.23 thousand +32.4%1.3%3.5 $1.54 11/30/202337,400 shares $62.08 thousand -17.8%1.0%3 $1.66 11/15/202345,500 shares $64.38 thousand -2.2%1.2%5.6 $1.42 10/31/202346,500 shares $58.66 thousand -7.7%1.3%6 $1.26 10/15/202350,400 shares $66.90 thousand +39.6%1.4%5.7 $1.33 9/30/202336,100 shares $42.01 thousand -43.9%1.1%3.3 $1.16 9/15/202364,300 shares $108.67 thousand +7.4%1.7%5.8 $1.69 8/31/202359,900 shares $103.63 thousand -9.5%1.7%5.1 $1.73 8/15/202366,200 shares $122.80 thousand -5.2%1.8%4.7 $1.86 7/31/202369,800 shares $122.85 thousand -7.4%1.9%4.7 $1.76 7/15/202375,400 shares $133.46 thousand -10.2%2.1%4.5 $1.77 6/30/202384,000 shares $153.72 thousand +7.4%2.3%4.5 $1.83 6/15/202378,200 shares $139.98 thousand +22.8%2.1%3.6 $1.79 5/31/202363,700 shares $116.57 thousand -0.6%1.7%2.9 $1.83 5/15/202364,100 shares $116.66 thousand No Change1.2%1.9 $1.82 BIAF Short Interest - Frequently Asked Questions What is bioAffinity Technologies' current short interest? Short interest is the volume of bioAffinity Technologies shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 985,900 shares of BIAF short. 4.78% of bioAffinity Technologies' shares are currently sold short. Learn More on bioAffinity Technologies' current short interest. What is a good short interest percentage for bioAffinity Technologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.78% of bioAffinity Technologies' floating shares are currently sold short. Is bioAffinity Technologies' short interest increasing or decreasing? bioAffinity Technologies saw a decrease in short interest in the month of August. As of August 15th, there was short interest totaling 985,900 shares, a decrease of 12.8% from the previous total of 1,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is bioAffinity Technologies' float size? bioAffinity Technologies currently has issued a total of 28,470,000 shares. Some of bioAffinity Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. bioAffinity Technologies currently has a public float of 20,610,000 shares. How does bioAffinity Technologies' short interest compare to its competitors? 4.78% of bioAffinity Technologies' shares are currently sold short. Here is how the short interest of companies compare to bioAffinity Technologies: ReShape Lifesciences Inc. (9.54%), HeartCore Enterprises, Inc. (1.14%), Scienjoy Holding Corporation (0.01%), VCI Global Limited (1.83%), GEE Group Inc. (0.19%), Guardforce AI Co., Limited (0.71%), Wilhelmina International, Inc. (0.01%), MOGU Inc. Sponsored ADR (0.04%), FlexShopper Inc. (1.18%), Cheer Holding, Inc. (1.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short bioAffinity Technologies stock? Short selling BIAF is an investing strategy that aims to generate trading profit from bioAffinity Technologies as its price is falling. BIAF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against bioAffinity Technologies? A short squeeze for bioAffinity Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIAF, which in turn drives the price of the stock up even further. How often is bioAffinity Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIAF, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies ReShape Lifesciences Short Interest Data HeartCore Enterprises Short Interest Data Scienjoy Short Interest Data VCI Global Short Interest Data GEE Group Short Interest Data Guardforce AI Short Interest Data Wilhelmina International Short Interest Data MOGU Short Interest Data FlexShopper Short Interest Data Cheer Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIAF) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
